
CC BY 4.0 · Wikimedia Commons · source file
A patient with biochemical evidence of a catecholamine-secreting tumor (elevated plasma metanephrines) has a negative CT of the adrenals. The nuclear medicine physician is choosing between MIBG scintigraphy and Ga-68 DOTATATE PET/CT for tumor localization. Which of the following statements is MOST accurate regarding imaging selection for paraganglioma?
A. Ga-68 DOTATATE PET/CT generally has superior sensitivity to MIBG for paraganglioma, particularly for SDH-mutated (hereditary) paragangliomas that have high SSTR expression
For paraganglioma localization, imaging selection should consider tumor genetics: (1) SDH-mutated paragangliomas (particularly SDHB mutations causing malignant paraganglioma) have high SSTR expression and are best imaged with Ga-68 DOTATATE PET/CT; (2) Sporadic head and neck paragangliomas (SDHx) also prefer DOTATATE; (3) Adrenal pheochromocytomas (especially sporadic or NF1/RET/VHL-related) typically respond well to MIBG; (4) I-131 MIBG therapy is used for metastatic MIBG-avid disease (pheochromocytoma/paraganglioma). Overall, Ga-68 DOTATATE PET/CT has shown superior sensitivity to MIBG for most paraganglioma subtypes in head-to-head comparisons.
Medications to Stop Before an MIBG Scan
Carcinoid Tumor on Somatostatin Receptor Imaging
OctreoScan: Why Delayed 24-Hour Images
OctreoScan Liver Uptake: Somatostatin Receptors
Normal FDG PET Biodistribution
OctreoScan (In-111 Octreotide): How It Localizes
All 130 nuclear medicine images by category →
All 130 images as an interactive quiz, alongside 500 NMTCB and ARRT(N) questions with worked explanations, case studies and timed mock exams. 25 questions are free, no card and no account.